Clinical Trial Details
| Trial ID: | L5193 |
| Source ID: | NCT03947879 |
| Associated Drug: | L-Glutamine |
| Title: | The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: L-glutamine|OTHER: No L-glutamine |
| Outcome Measures: | Primary: Change in fasting glucose, Change in fasting glucose, 3 months and 6 months|Change in hemoglobin A1c, Change in hemoglobin A1c, 3 months and 6 months | Secondary: Change in fructosamine, Change in fructosamine level, 3 months and 6 months|Change in complete blood count, Change in complete blood count, 3 months and 6 months|Change in blood chemistry, Change in blood chemistry, 3 months and 6 months|Change in hepatic function, Chang e in hepatic function, 3 months and 6 months|Change in microablbumin, Change in urine microalbumin, 3 months and 6 months|Change in weight, Change in weight, 3 months and 6 months|Change in waist circumference, Change in waist circumference, 3 months and 6 months |
| Sponsor/Collaborators: | Sponsor: Hawaii Pacific Health |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 25 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2019-05 |
| Completion Date: | 2022-05 |
| Results First Posted: | |
| Last Update Posted: | 2019-05-13 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT03947879 |
